Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.50 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | GLA | P06280 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | GPR3 | P46089 | 1/20 | 0.48 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.46 |
| ▸ | NQO2 | P16083 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | GABRP | O00591 | 1/20 | 0.39 |
| ▸ | GABRD | O14764 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16376455 | 0.82 | GPR3 (0.70) | ALKBH5FTOKDM4EALDH1A1GLA | |
| SCHEMBL19233675 | 0.79 | ALKBH5 (0.45) | ALKBH5FTOKDM4EALDH1A1GLA | |
| SCHEMBL19233652 | 0.79 | ALKBH5 (0.53) | ALKBH5FTOKDM4EALDH1A1GLA | |
| SCHEMBL19233713 | 0.78 | ALKBH5 (0.50) | ALKBH5FTOKDM4EALDH1A1GLA | |
| SCHEMBL3423943 | 0.73 | GPR3 (0.71) | ALKBH5FTOKDM4EALDH1A1GLA | |
| SCHEMBL1181056 | 0.73 | ALKBH5 (0.58) | ALKBH5FTOKDM4EALDH1A1GLA | |
| SCHEMBL19233707 | 0.73 | KDM4E (0.47) | ALKBH5FTOKDM4EALDH1A1GLA | |
| SCHEMBL19797662 | 0.72 | KDM4E (0.66) | ALKBH5FTOKDM4EALDH1A1GLA | |
| SCHEMBL19797643 | 0.72 | KDM4E (0.66) | ALKBH5FTOKDM4EALDH1A1GLA | |
| SCHEMBL19797639 | 0.72 | KDM4E (0.66) | ALKBH5FTOKDM4EALDH1A1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11716898-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-01 | — | — | US | disclosed |
| US-20200295276-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORP (US) | 2020-09-17 | — | — | US | disclosed |
| US-10707427-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-07-07 | — | — | US | disclosed |
| US-20170237018-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2017-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170237018-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, JUND | ALKBH5 595/4885FTO 61/4885KDM4E 2637/4885 |
| US-11716898-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | ALKBH5 595/4885FTO 61/4885KDM4E 2637/4885 |
| US-10707427-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | ALKBH5 371/4885FTO 140/4885KDM4E 3150/4885 |
| US-20200295276-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, JUND | ALKBH5 595/4885FTO 61/4885KDM4E 2637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.